Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Clinical-trials-phase-iii    symbols : ALLK    save search
Allakos Announces Topline Phase 3 Data from the EoDyssey Study in Patients with Eosinophilic Duodenitis
Published: 2022-09-09 (Crawled : 22:00) - biospace.com/
ALLK | $1.09 0.93% 180K twitter stocktwits trandingview |
Health Technology
 | | O: -8.41% H: 18.12% C: 15.41%
topline study
Allakos Completes Patient Enrollment in Phase 3 Eosinophilic Gastritis and/or Eosinophilic Duodenitis and Phase 2/3 Eosinophilic Esophagitis Clinical Trials of Lirentelimab (AK002)
Published: 2021-06-07 (Crawled : 18:00) - biospace.com/
ALLK | $1.09 0.93% 180K twitter stocktwits trandingview |
Health Technology
 | | O: -0.12% H: 4.21% C: 2.01%
phase 2 clinical trials phase 2/3 phase 3 trial enroll
Gainers vs Losers
54% 46%

Top 10 Gainers
WISA 4 | $7.86 349.14% 120M twitter stocktwits trandingview |
Electronic Technology
TPET | $0.4951 114.24% 29M twitter stocktwits trandingview |
n/a
JAGX | $0.1771 49.07% 540M twitter stocktwits trandingview |
Health Technology
SXTC | $2.03 45.0% 27M twitter stocktwits trandingview |
Health Technology
SPCB | $0.3888 40.87% 27M twitter stocktwits trandingview |
Electronic Technology
DYNT | $0.52 40.39% 20M twitter stocktwits trandingview |
Health Technology
SNGX | $0.54 39.86% 7.3M twitter stocktwits trandingview |
Health Technology
BSGM | $1.53 39.09% 2.6M twitter stocktwits trandingview |
Health Technology
MCBC | $13.74 38.37% 1.6M twitter stocktwits trandingview |
Finance
PALI | $5.51 32.45% 28M twitter stocktwits trandingview |
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.